From Medscape Neurology

Coverage from the

Consortium of Multiple Sclerosis Centers (CMSC) 2018 Annual Meeting

May 30 - June 02, 2018; Nashville, Tennessee

May 30 - June 02, 2018 Nashville, Tennessee

Conference News

Popular News from CMSC 2017

  • Discontinuing Disease-Modifying Therapy in MS Discontinuing Disease-Modifying Therapy in MS A literature review suggests stopping therapy might be considered in certain subsets of patients later in the disease course, researchers say. Others call the idea 'dangerous.'
  • Should All Patients With MS Receive Aggressive Treatment? Should All Patients With MS Receive Aggressive Treatment? With numerous agents for multiple sclerosis seemingly more effective than older drugs in halting disease activity, can a case be made for starting all newly diagnosed patients on them?
  • Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed changes is a greater role for cerebrospinal fluid evaluation.

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

CMSC on Twitter

Previous Coverage